These autoantibodies are broadly classified into myositis-specific autoantibodies (MSAs), which are unique to IIM, and myositis-associated autoantibodies (MAAs), which may overlap with other autoimmune conditions. Here, MAPKAPK5-AS1 is linked to myositis disease.